苏州生物医药产业研究及“十三五”发展建议  

Study on Biological Medicine Industry in Suzhou and Advices in the Thirteenth Five-year

作　　者：韩子睿[1] 张雯[1] 

机构地区：[1]江苏省科学技术情报研究所,南京210042

出　　处：《科技和产业》2015年第4期22-29,共8页Science Technology and Industry

基　　金：苏州市科技局指令性研究课题(SS201416)

摘　　要：系统梳理了苏州生物医药产业发展的总体情况,发现其在产业技术、企业培育、人才引进、平台建设等方面都具有较强优势,特别是小核酸药物、纳米生物医药、抗体诊断、医学工程等领域已跻身国际前沿,与发达国家处在"同一起跑线"。同时,深入分析了当前产业发展的瓶颈制约和面临形势,主要还存在产业规模不大、创新动力不足、成果转化不畅等突出问题,结合苏州实际,分领域提出了"十三五"时期苏州生物医药产业发展的方向与重点。Based on arranging the general situation,this article finds out that the Medicine Industry in Suzhou has a great advantage on industrial technology,business incubating,talent introduction,platform construction and so on.In particular,nanomedicine,antibody test and medical engineering are on the same starting line with the developed countries.At the same time,this article analyses the current problems and situation of the industry deeply,and puts forward the developmental emphases in the thirteenth five-year with the practice of Suzhou.

关 键 词：苏州 医疗器械 生物医药 生物技术 新兴产业 

分 类 号：R197[医药卫生—卫生事业管理]